Abstract:Background: Chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM) is a gene family involved in multiple malignancies. CMTM4 is a member of this family and is located at chromosome 16q22.1, a locus that harbours a number of tumour suppressor genes. It has been defined as a regulator of cell cycle and division in HeLa cells; however, its roles in tumourigenesis remain poorly studied. Methods: An integrated bioinformatics analysis based on the array data from the GEO database was conducted to view the differential expression of CMTM4 across multiple cancers and their corresponding control tissues. Primary clear cell renal cell carcinoma (ccRCC) and the paired adjacent non-tumour tissues were then collected to examine the expression of CMTM4 by western blotting, immunohistochemistry, and quantitative RT-PCR. The ccRCC cell lines A498 and 786-O and the normal renal tubular epithelial cell line HK-2 were also tested for CMTM4 expression by western blotting. Cell Counting Kit-8 (CCK-8) and viable cell counting assays were used to delineate the growth curves of 786-O cells after CMTM4 overexpression or knockdown. Wound healing and transwell assays were performed to assess the cells' ability to migrate. The effects of CMTM4 on cellular apoptosis and cell cycle progression were analysed by flow cytometry, and cell cycle hallmarks were detected by western blotting and RT-PCR. The xenograft model in nude mice was used to elucidate the function of CMTM4 in tumourigenesis ex vivo. Results: By omic data analysis, we found a substantial downregulation of CMTM4 in ccRCC. Western blotting then confirmed that CMTM4 was dramatically reduced in 86.9 % (53/61) of ccRCC tissues compared with the paired adjacent non-tumour tissues, as well as in the 786-O and A498 ccRCC cell lines. Restoration of CMTM4 significantly suppressed 786-O cell growth by inducing G2/M cell cycle arrest and p21 upregulation, and cell migration was also inhibited. However, knockdown of CMTM4 led to a completely opposite effect on these cell behaviours. Overexpression of CMTM4 also markedly inhibited the tumour xenograft growth in nude mice. Conclusions: CMTM4 is downregulated and exhibits tumour-suppressor activities in ccRCC, and could be exploited as a target for ccRCC treatment.

CMTM4 Inhibits Cell Proliferation and Migration Via AKT, ERK1/2, and STAT3 Pathway in Colorectal Cancer

CMTM4 is Frequently Downregulated and Functions As a Tumour Suppressor in Clear Cell Renal Cell Carcinoma

CRMP4 Suppresses Cervical Cancer Cell Proliferation and EMT Through the Wnt/β-catenin Pathway

CMTM4 inhibits gastric tumorigenesis and metastasis

A novel methylated cation channel TRPM4 inhibited colorectal cancer metastasis through Ca<SUP>2+</SUP>/Calpain-mediated proteolysis of FAK and suppression of PI3K/Akt/mTOR signaling pathway

Cmtm3, Located At The Critical Tumor Suppressor Locus 16q22.1, Is Silenced By Cpg Methylation In Carcinomas And Inhibits Tumor Cell Growth Through Inducing Apoptosis

Tmprss4 Correlates With Colorectal Cancer Pathological Stage And Regulates Cell Proliferation And Self-Renewal Ability

New Tumor Suppressor Cxxc Finger Protein 4 Inactivates Mitogen Activated Protein Kinase Signaling

Cmtm3 Inhibits Cell Migration And Invasion And Correlates With Favorable Prognosis In Gastric Cancer

CMTM3 is Frequently Reduced in Clear Cell Renal Cell Carcinoma and Exhibits Tumor Suppressor Activities

Data from <i>CMTM3</i>, Located at the Critical Tumor Suppressor Locus 16q22.1, Is Silenced by CpG Methylation in Carcinomas and Inhibits Tumor Cell Growth through Inducing Apoptosis

TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer

MicroRNA-206 Attenuates Tumor Proliferation and Migration Involving the Downregulation of NOTCH3 in Colorectal Cancer.

CMTM3 Decreases EGFR Expression and EGF-mediated Tumorigenicity by Promoting Rab5 Activity in Gastric Cancer.

CMTM3 Inhibits Cell Growth and Migration and Predicts Favorable Survival in Oral Squamous Cell Carcinoma

ECRG4 Acts As a Tumor Suppressor Gene Frequently Hypermethylated in Human Breast Cancer.

Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.

Down-regulation of TMPRSS4 expression inhibits the cell proliferation and migration of colon cancer cells

MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway

AB179. CMTM3 is Reduced in Prostate Cancer and Inhibits Migration, Invasion and Growth of LNCaP Cells

CMTM3 Inhibits Human Testicular Cancer Cell Growth Through Inducing Cell-Cycle Arrest and Apoptosis